Uncategorized @en-us

While the world fights through COVID19 pandemic EUSA and Papa Giovani Hospital in Italy had initiated an observational study (SISCO trial - https://clinicaltrials.gov/ct2/show/NCT04322188?term=SISCO&draw=2&rank=1)  on Siltuximab (Sylvant©). EUSA has published the following Press Release on the subject - https://www.eusapharma.com/news/interim-analysis-data-for-siltuximab-treated-covid-19-patients-from-the-sisco-study/ and preliminary results could be found here...